HSBC Turns Bullish on Adobe: $308 Price Target Signals 46% Upside
The upgrade highlights Adobe’s resilience to AI disruption and its attractive valuation.
Already have an account? Sign in.
The upgrade highlights Adobe’s resilience to AI disruption and its attractive valuation.
BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.
Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.
Genuine Parts lowered its 2026 profit outlook amid weaker consumer demand. CEO Will Stengel denied rumors of a rival acquiring its automotive business.